We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
+5.89%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+359.15%
AUM
$39.5B
AUM Growth
+$4.37B
Cap. Flow
+$2.48B
Cap. Flow %
6.28%
Top 10 Hldgs %
5.86%
Holding
3,447
New
176
Increased
1,376
Reduced
1,602
Closed
253

Sector Composition

Rank Sector Weight
1 Financials 10.78%
2 Consumer Discretionary 10.44%
3 Technology 10.24%
4 Industrials 10.05%
5 Energy 9.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABMD
2076
DELISTED
Abiomed Inc
ABMD
$1.38M ﹤0.01%
54,840
-7,024
-11% -$163K
ANN
2077
DELISTED
ANN INC
ANN
$1.38M ﹤0.01%
33,502
-4,867
-13% -$194K
TER icon
2078
Teradyne
TER
$56.9B
$1.37M ﹤0.01%
69,978
+27,163
+63% +$505K
EQY
2079
DELISTED
Equity One
EQY
$1.37M ﹤0.01%
58,041
-12,735
-18% -$290K
OMCL icon
2080
Omnicell
OMCL
$1.68B
$1.37M ﹤0.01%
47,653
-6,178
-11% -$167K
ESL
2081
DELISTED
Esterline Technologies
ESL
$1.37M ﹤0.01%
11,881
+1,437
+14% +$159K
CCRN
2082
DELISTED
Cross Country Healthcare
CCRN
$1.37M ﹤0.01%
209,610
-20,029
-9% -$132K
PEO
2083
Adams Natural Resources Fund
PEO
$740M
$1.37M ﹤0.01%
45,553
+20,766
+84% +$588K
ATR icon
2084
AptarGroup
ATR
$8.6B
$1.36M ﹤0.01%
20,334
+4,458
+28% +$296K
NTUS
2085
DELISTED
Natus Medical Inc
NTUS
$1.36M ﹤0.01%
54,081
-6,994
-11% -$173K
AEO icon
2086
American Eagle Outfitters
AEO
$2.92B
$1.36M ﹤0.01%
121,005
+12,435
+11% +$141K
CMD
2087
DELISTED
Cantel Medical Corporation
CMD
$1.36M ﹤0.01%
37,032
-1,496
-4% -$50.8K
YORW icon
2088
York Water
YORW
$502M
$1.35M ﹤0.01%
65,047
+3,602
+6% +$72.9K
DSM
2089
BNY Mellon Strategic Municipal Bond Fund
DSM
$286M
$1.34M ﹤0.01%
161,812
-22,518
-12% -$182K
OAK
2090
DELISTED
OAKTREE CAPITAL GROUP, LLC
OAK
$1.34M ﹤0.01%
26,778
-20,275
-43% -$1.05M
SC
2091
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
$1.34M ﹤0.01%
+68,838
New +$1.47M
HOMB icon
2092
Home BancShares
HOMB
$6.25B
$1.34M ﹤0.01%
81,476
-13,622
-14% -$220K
AMSF icon
2093
AMERISAFE
AMSF
$562M
$1.33M ﹤0.01%
32,834
-198
-0.6% -$7.88K
CULP icon
2094
Culp Inc
CULP
$45.5M
$1.33M ﹤0.01%
76,593
+12,553
+20% +$229K
PBH icon
2095
Prestige Consumer Healthcare
PBH
$2.46B
$1.33M ﹤0.01%
39,304
-8,095
-17% -$259K
MDSO
2096
DELISTED
Medidata Solutions, Inc.
MDSO
$1.33M ﹤0.01%
31,119
-2,831
-8% -$118K
NXQ
2097
DELISTED
NUVEEN ELECT TAX-FREE INC 2
NXQ
$1.33M ﹤0.01%
97,252
+20,670
+27% +$276K
ALDW
2098
DELISTED
Alon USA Partners LP
ALDW
$1.33M ﹤0.01%
74,186
-3,296
-4% -$59.7K
VIAV icon
2099
Viavi Solutions
VIAV
$9.3B
$1.33M ﹤0.01%
186,944
-9,792
-5% -$66.6K
YELP icon
2100
Yelp
YELP
$1.47B
$1.33M ﹤0.01%
17,291
-6,884
-28% -$448K

Similar funds

Guggenheim Capital's Q2 2014 Portfolio in Review

As of Q2 2014, Guggenheim Capital held 3,447 positions worth $39.5B, up 12% from $35.2B the previous quarter. Its ten largest holdings account for 5.9% of the portfolio.

Guggenheim Capital deployed $2.48B of net new capital in Q2 2014, opening 176 new positions and adding to 1,376 existing holdings. Its largest new stake was DIAMOND RESORTS INTL, INC: 11,338,566 shares worth $264M.

By sector, the portfolio is most concentrated in Financials at 11% of assets, down from 11% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $95.8M trimmed.

  • Guggenheim Capital's largest Q2 2014 buy was DIAMOND RESORTS INTL, INC: 11,338,566 shares worth $264M.
  • Guggenheim Capital added most to Stanley Black & Decker in Q2 2014, an estimated $62.1M increase.
  • Guggenheim Capital's biggest Q2 2014 reduction was iShares Russell 2000 ETF, cutting an estimated $95.8M.
  • Guggenheim Capital fully exited LSI CORPORATION in Q2 2014, selling an estimated $44.6M.
  • Guggenheim Capital's ten largest holdings make up 5.9% of its $39.5B portfolio in Q2 2014.
  • Guggenheim Capital opened 176 new positions and closed 253 in Q2 2014.
  • Guggenheim Capital's portfolio value rose 12% quarter-over-quarter to $39.5B.

Based on Guggenheim Capital's 13F filing for Q2 2014, filed 14 Aug 2014.